BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34770780)

  • 1. Separation of
    Larenkov AA; Makichyan AG; Iatsenko VN
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application.
    Pruszyński M; Loktionova NS; Filosofov DV; Rösch F
    Appl Radiat Isot; 2010 Sep; 68(9):1636-41. PubMed ID: 20434351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
    Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
    Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system.
    Roesch F
    Curr Radiopharm; 2012 Jul; 5(3):187-201. PubMed ID: 22642388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclotron production of high purity (44m,44)Sc with deuterons from (44)CaCO3 targets.
    Alliot C; Kerdjoudj R; Michel N; Haddad F; Huclier-Markai S
    Nucl Med Biol; 2015 Jun; 42(6):524-9. PubMed ID: 25794463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
    Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
    J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of
    Radchenko V; Meyer CAL; Engle JW; Naranjo CM; Unc GA; Mastren T; Brugh M; Birnbaum ER; John KD; Nortier FM; Fassbender ME
    J Chromatogr A; 2016 Dec; 1477():39-46. PubMed ID: 27903405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets.
    Loveless CS; Blanco JR; Diehl GL; Elbahrawi RT; Carzaniga TS; Braccini S; Lapi SE
    J Nucl Med; 2021 Jan; 62(1):131-136. PubMed ID: 32620699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hydroxamate-based resins towards a more clinically viable
    Gajecki L; Marino CM; Cutler CS; Sanders VA
    Appl Radiat Isot; 2023 Feb; 192():110588. PubMed ID: 36470155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High Separation Factor for
    Da Silva I; Johnson TR; Mixdorf JC; Aluicio-Sarduy E; Barnhart TE; Nickles RJ; Engle JW; Ellison PA
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946596
    [No Abstract]   [Full Text] [Related]  

  • 12. [
    Li L; Jaraquemada-Peláez MG; Aluicio-Sarduy E; Wang X; Jiang D; Sakheie M; Kuo HT; Barnhart TE; Cai W; Radchenko V; Schaffer P; Lin KS; Engle JW; Bénard F; Orvig C
    Inorg Chem; 2020 Feb; 59(3):1985-1995. PubMed ID: 31976659
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc.
    Pruszyński M; Majkowska-Pilip A; Loktionova NS; Eppard E; Roesch F
    Appl Radiat Isot; 2012 Jun; 70(6):974-9. PubMed ID: 22464928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton-induced production and radiochemical isolation of
    Radchenko V; Engle JW; Medvedev DG; Maassen JM; Naranjo CM; Unc GA; Meyer CAL; Mastren T; Brugh M; Mausner L; Cutler CS; Birnbaum ER; John KD; Nortier FM; Fassbender ME
    Nucl Med Biol; 2017 Jul; 50():25-32. PubMed ID: 28432915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
    Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined inorganic-organic titanium-44/scandium-44g radiochemical generator.
    Klouda J; Fassbender ME; Mocko V
    J Chromatogr A; 2023 Nov; 1711():464438. PubMed ID: 37857154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach.
    Lahnif H; Grus T; Pektor S; Greifenstein L; Schreckenberger M; Rösch F
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved procedures of Sc(OH)3 precipitation and UTEVA extraction for 44Sc separation.
    Wojdowska W; Pawlak D; Cieszykowska I; Żółtowska M; Janiak T; Barcikowski T; Stolarz A; Choiński J; Parus J; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2019; 22(2):56-59. PubMed ID: 31482557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals.
    Majkowska-Pilip A; Bilewicz A
    J Inorg Biochem; 2011 Feb; 105(2):313-20. PubMed ID: 21194633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Labeling PSMA
    Eppard E; Homann T; de la Fuente A; Essler M; Rösch F
    J Nucl Med; 2017 Mar; 58(3):432-437. PubMed ID: 28082433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.